Matches in SemOpenAlex for { <https://semopenalex.org/work/W2619523021> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2619523021 abstract "Background For more than 60 years, warfarin has been the mainstay anticoagulation therapy worldwide. Since 2008, direct oral anticoagulants (DOACs) have been introduced to the market which expands the options for healthcare practitioners to find new alternatives to warfarin for the treatment and prevention of atrial fibrillation and thromboembolic events. Domestically, dabigatran was introduced in 2011 followed by rivaroxaban in 2014. The global use of DOACs is increasing, yet we have little knowledge with regard to the adoption of DOACs into local clinical practice. Purpose This study aimed to explore the local prescribing trends of oral anticoagulants over a 5 year period (from 2011 to 2015). Also, we aimed to explore the switching pattern among anticoagulants, from warfarin to DOACs and vice versa. Material and methods A time series analysis was conducted using patient electronic medical records of dispensed prescriptions (inpatient or outpatient) from the main medical corporation in the country to assess the use of oral anticoagulants between the period January 2011 until the end of October 2015. For every calendar year, the data obtained were used to quantify the percentage of patients using each agent. Results 7178 patients used oral anticoagulants over the past 5 years: 6044 (84.2%) used warfarin, 518 (7.2%) used dabigatran and 616 (8.6%) used rivaroxaban. There was a gradual increase in the percentage of patients receiving DOACs from 0.5% in 2011 to 26% in 2015. Similarly, among DOACs users, 261 (22.3%) were previous warfarin users while 188 (16.1%) patients who were using DOACs were switched back to warfarin. Conclusion A gradual growth in DOACs use has been observed in local practice with a trend similar to other countries. Yet, until today, warfarin remains the most used oral anticoagulant. References and/or acknowledgements Please note that the country/hospital name has been removed from the abstract title/text. However, the study took place in Qatar and it is a crucial part of the abstract as it is evaluating the practice in Qatar. No conflict of interest" @default.
- W2619523021 created "2017-06-05" @default.
- W2619523021 creator A5002370707 @default.
- W2619523021 creator A5024650756 @default.
- W2619523021 creator A5039045493 @default.
- W2619523021 creator A5051611634 @default.
- W2619523021 creator A5079545875 @default.
- W2619523021 date "2017-02-25" @default.
- W2619523021 modified "2023-09-27" @default.
- W2619523021 title "CP-073 Trends in oral anticoagulant use: a 5 year experience" @default.
- W2619523021 doi "https://doi.org/10.1136/ejhpharm-2017-000640.72" @default.
- W2619523021 hasPublicationYear "2017" @default.
- W2619523021 type Work @default.
- W2619523021 sameAs 2619523021 @default.
- W2619523021 citedByCount "0" @default.
- W2619523021 crossrefType "proceedings-article" @default.
- W2619523021 hasAuthorship W2619523021A5002370707 @default.
- W2619523021 hasAuthorship W2619523021A5024650756 @default.
- W2619523021 hasAuthorship W2619523021A5039045493 @default.
- W2619523021 hasAuthorship W2619523021A5051611634 @default.
- W2619523021 hasAuthorship W2619523021A5079545875 @default.
- W2619523021 hasConcept C126322002 @default.
- W2619523021 hasConcept C177713679 @default.
- W2619523021 hasConcept C194828623 @default.
- W2619523021 hasConcept C2426938 @default.
- W2619523021 hasConcept C2776301958 @default.
- W2619523021 hasConcept C2778661090 @default.
- W2619523021 hasConcept C2778810321 @default.
- W2619523021 hasConcept C2779161974 @default.
- W2619523021 hasConcept C2780638905 @default.
- W2619523021 hasConcept C2992750412 @default.
- W2619523021 hasConcept C71924100 @default.
- W2619523021 hasConcept C98274493 @default.
- W2619523021 hasConceptScore W2619523021C126322002 @default.
- W2619523021 hasConceptScore W2619523021C177713679 @default.
- W2619523021 hasConceptScore W2619523021C194828623 @default.
- W2619523021 hasConceptScore W2619523021C2426938 @default.
- W2619523021 hasConceptScore W2619523021C2776301958 @default.
- W2619523021 hasConceptScore W2619523021C2778661090 @default.
- W2619523021 hasConceptScore W2619523021C2778810321 @default.
- W2619523021 hasConceptScore W2619523021C2779161974 @default.
- W2619523021 hasConceptScore W2619523021C2780638905 @default.
- W2619523021 hasConceptScore W2619523021C2992750412 @default.
- W2619523021 hasConceptScore W2619523021C71924100 @default.
- W2619523021 hasConceptScore W2619523021C98274493 @default.
- W2619523021 hasLocation W26195230211 @default.
- W2619523021 hasOpenAccess W2619523021 @default.
- W2619523021 hasPrimaryLocation W26195230211 @default.
- W2619523021 hasRelatedWork W2025124206 @default.
- W2619523021 hasRelatedWork W2069793824 @default.
- W2619523021 hasRelatedWork W2561849086 @default.
- W2619523021 hasRelatedWork W2562101665 @default.
- W2619523021 hasRelatedWork W2582505536 @default.
- W2619523021 hasRelatedWork W2597994540 @default.
- W2619523021 hasRelatedWork W2736956220 @default.
- W2619523021 hasRelatedWork W2764335093 @default.
- W2619523021 hasRelatedWork W2780746271 @default.
- W2619523021 hasRelatedWork W2782823495 @default.
- W2619523021 hasRelatedWork W2898683557 @default.
- W2619523021 hasRelatedWork W2951901519 @default.
- W2619523021 hasRelatedWork W3015066155 @default.
- W2619523021 hasRelatedWork W3081405778 @default.
- W2619523021 hasRelatedWork W3094076911 @default.
- W2619523021 hasRelatedWork W3108112987 @default.
- W2619523021 hasRelatedWork W3134910881 @default.
- W2619523021 hasRelatedWork W3137989749 @default.
- W2619523021 hasRelatedWork W3212726718 @default.
- W2619523021 hasRelatedWork W826970266 @default.
- W2619523021 isParatext "false" @default.
- W2619523021 isRetracted "false" @default.
- W2619523021 magId "2619523021" @default.
- W2619523021 workType "article" @default.